Advantageous Solubility-Permeability Interplay When Using Amorphous Solid Dispersion (ASD) Formulation for the BCS Class IV P-gp Substrate Rifaximin: Simultaneous Increase of Both the Solubility and the Permeability-Reference-Cited by-同舟云学术

Advantageous Solubility-Permeability Interplay When Using Amorphous Solid Dispersion (ASD) Formulation for the BCS Class IV P-gp Substrate Rifaximin: Simultaneous Increase of Both the Solubility and the Permeability

Published:2017-02-15 Issue:3 Volume:19 Page:806-813
ISSN:1550-7416
Container-title:The AAPS Journal
language:en
Short-container-title:AAPS J

Author:

Beig Avital,Fine-Shamir Noa,Lindley David,Miller Jonathan M,Dahan Arik

Publisher

Springer Science and Business Media LLC

Subject

Pharmaceutical Science

Link

http://link.springer.com/content/pdf/10.1208/s12248-017-0052-1.pdf

Reference52 articles.

1. Dahan A, Wolk O, Kim YH, Ramachandran C, Crippen GM, Takagi T, et al. Purely in silico BCS classification: science based quality standards for the world’s drugs. Mol Pharm. 2013;10:4378–90.

2. Lipinski CA, Lombardo F, Dominy BW, Feeney PJ. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev. 2001;46:3–26.

3. Dahan A, Beig A, Lindley D, Miller JM. The solubility–permeability interplay and oral drug formulation design: two heads are better than one. Adv Drug Deliv Rev. 2016;101:99–107.

4. Dahan A, Miller J. The solubility–permeability interplay and its implications in formulation design and development for poorly soluble drugs. AAPS J. 2012;14:244–51.

5. Amidon GL, Lennernas H, Shah VP, Crison JR. A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm Res. 1995;12:413.

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring biorelevant conditions and release profiles of ritonavir from HPMCAS-based amorphous solid dispersions;Journal of Pharmaceutical Sciences;2024-08

2. Investigation of Stabilized Amorphous Solid Dispersions to Improve Oral Olaparib Absorption;Pharmaceutics;2024-07-19

3. Sweeteners Show a Plasticizing Effect on PVP K30—A Solution for the Hot-Melt Extrusion of Fixed-Dose Amorphous Curcumin-Hesperetin Solid Dispersions;Pharmaceutics;2024-05-15

4. Impact of crystal polymorphism of rifaximin on dissolution behavior;Heliyon;2024-03

5. Ethanol-based solubility-enabling oral drug formulation development: Accounting for the solubility-permeability interplay;International Journal of Pharmaceutics;2024-03